You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Hepatitis

Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C

  • Technology appraisal guidance
  • Reference number: TA200
  • Published:  22 September 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • History

TA200 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - provisional matrix of stakeholders

TA200 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - provisional matrix of stakeholders TA200 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - provisional matrix of stakeholders
14 October 2013
(100.31 Kb 29 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 10 October 2013

Back to top